{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:43:06Z","timestamp":1790620986062,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.bpg.2011.10.002","type":"journal-article","created":{"date-parts":[[2011,11,30]],"date-time":"2011-11-30T16:19:03Z","timestamp":1322669943000},"page":"753-764","source":"Crossref","is-referenced-by-count":68,"title":["Primary sclerosing cholangitis and malignancy"],"prefix":"10.1016","volume":"25","author":[{"given":"Kirsten Muri","family":"Boberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guro E.","family":"Lind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2011.10.002_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.002_bib2","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broom\u00e9","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2011.10.002_bib3","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.002_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","article-title":"Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study","volume":"102","author":"Tischendorf","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.002_bib5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis","volume":"99","author":"Burak","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.002_bib6","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1007\/s10620-006-9681-4","article-title":"Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"52","author":"Fevery","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2011.10.002_bib7","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/hep.22441","article-title":"Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis","volume":"48","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.002_bib8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis","volume":"50","author":"Claessen","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.002_bib9","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/hep.22310","article-title":"Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment","volume":"48","author":"Blechacz","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.002_bib10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MOG.0b013e328337b311","article-title":"An update on cholangiocarcinoma associated with primary sclerosing cholangitis","volume":"26","author":"Fevery","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.002_bib11","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.002_bib12","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/carcin\/bgp118","article-title":"Catalytically impaired hMYH and NEIL1 mutant proteins identified in patients with primary sclerosing cholangitis and cholangiocarcinoma","volume":"30","author":"Forsbring","year":"2009","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bpg.2011.10.002_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/hep.21964","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms","volume":"47","author":"Melum","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.002_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1148\/radiology.207.1.9530297","article-title":"Biliary tract carcinoma complicating primary sclerosing cholangitis: evaluation with CT, cholangiography, US, and MR imaging","volume":"207","author":"Campbell","year":"1998","journal-title":"Radiology"},{"key":"10.1016\/j.bpg.2011.10.002_bib15","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1080\/00365520802200002","article-title":"Perihilar lymph nodes in patients with primary sclerosing cholangitis with and without cholangiocellular carcinoma","volume":"43","author":"Kirchner","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.002_bib16","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/hep.21433","article-title":"Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation","volume":"44","author":"Prytz","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.002_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.002_bib18","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1572-0241.2006.00383.x","article-title":"Is there a role for cholangioscopy in patients with primary sclerosing cholangitis?","volume":"101","author":"Awadallah","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.002_bib19","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1080\/00365520701206761","article-title":"Transpapillary intraductal ultrasound in the evaluation of dominant bile duct stenoses in patients with primary sclerosing cholangitis","volume":"42","author":"Tischendorf","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.002_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PAS.0b013e3181bc96f9","article-title":"Precancerous bile duct pathology in end-stage primary sclerosing cholangitis, with and without cholangiocarcinoma","volume":"34","author":"Lewis","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bpg.2011.10.002_bib21","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jhep.2006.05.010","article-title":"Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis","volume":"45","author":"Boberg","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.002_bib22","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1053\/j.gastro.2006.08.021","article-title":"Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures","volume":"131","author":"Moreno Luna","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.002_bib23","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/hep.23277","article-title":"Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis","volume":"51","author":"Bangarulingam","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.002_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/MOG.0b013e328325a894","article-title":"Serum and bile biomarkers for cholangiocarcinoma","volume":"25","author":"Alvaro","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.002_bib25","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1007\/s10620-005-2927-8","article-title":"The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis","volume":"50","author":"Levy","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2011.10.002_bib26","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cgh.2011.02.007","article-title":"Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinoma","volume":"9","author":"Sinakos","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2011.10.002_bib27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2007.05.017","article-title":"Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures","volume":"47","author":"Lempinen","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.002_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1470-2045(08)70027-5","article-title":"Circulating markers of biliary malignancy: opportunities in proteomics?","volume":"9","author":"Bonney","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpg.2011.10.002_bib29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/hep.24103","article-title":"Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis","volume":"53","author":"Lankisch","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.002_bib30","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/02841850802220092","article-title":"Detection of cholangiocarcinoma with magnetic resonance spectroscopy of bile in patients with and without primary sclerosing cholangitis","volume":"49","author":"Albiin","year":"2008","journal-title":"Acta Radiol"},{"key":"10.1016\/j.bpg.2011.10.002_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-2008-1040419","article-title":"Cholangiocarcinoma complicating primary sclerosing cholangitis","volume":"11","author":"Rosen","year":"1991","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2011.10.002_bib32","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1572-0241.2001.03696.x","article-title":"Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo clinic experience","volume":"96","author":"Kaya","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.002_bib33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1091-255X(99)80051-1","article-title":"Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis","volume":"3","author":"Ahrendt","year":"1999","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.bpg.2011.10.002_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/145749691110000106","article-title":"Cholangiocarcinoma \u2013 current treatment options","volume":"100","author":"Friman","year":"2011","journal-title":"Scand J Surg"},{"key":"10.1016\/j.bpg.2011.10.002_bib35","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jhep.2004.01.021","article-title":"Liver transplantation for primary sclerosing cholangitis","volume":"40","author":"Bjoro","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.002_bib36","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3109\/00365521.2010.533384","article-title":"Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results","volume":"46","author":"Friman","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.002_bib37","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1097\/01.tp.0000253551.43583.d1","article-title":"Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma","volume":"82","author":"Heimbach","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bpg.2011.10.002_bib38","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1034\/j.1600-6143.2002.20812.x","article-title":"Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma","volume":"2","author":"Sudan","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bpg.2011.10.002_bib39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1055\/s-2006-933562","article-title":"Primary sclerosing cholangitis and cholangiocarcinoma","volume":"26","author":"Lazaridis","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2011.10.002_bib40","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2011.10.002_bib41","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jhep.2010.10.010","article-title":"Combination of gemcitabine and cisplatin for biliary tract cancer: a platform to build on","volume":"54","author":"Razumilava","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.002_bib42","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2214\/ajr.150.3.571","article-title":"Gallbladder disease in patients with primary sclerosing cholangitis","volume":"150","author":"Brandt","year":"1988","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.bpg.2011.10.002_bib43","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/j.1572-0241.2002.05677.x","article-title":"In primary sclerosing cholangitis, gallbladder polyps are frequently malignant","volume":"97","author":"Buckles","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.002_bib44","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/01.pas.0000213435.99492.8a","article-title":"Prevalence and risk factors for gallbladder neoplasia in patients with primary sclerosing cholangitis: evidence for a metaplasia\u2013dysplasia\u2013carcinoma sequence","volume":"31","author":"Lewis","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bpg.2011.10.002_bib45","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.11.019","article-title":"Gallbladder disease in patients with primary sclerosing cholangitis","volume":"48","author":"Said","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.002_bib46","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0168-8278(97)80356-X","article-title":"Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer?","volume":"27","author":"Harnois","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.002_bib47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/ajg.2010.428","article-title":"The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study","volume":"106","author":"Baars","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.002_bib48","first-page":"1404","article-title":"Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential","volume":"22","author":"Broom\u00e9","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.002_bib49","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/j.1572-0241.1999.01156.x","article-title":"The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis","volume":"94","author":"Shetty","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.002_bib50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.bpg.2011.10.002_bib51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2006-933561","article-title":"Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer","volume":"26","author":"Broom\u00e9","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2011.10.002_bib52","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/DCR.0b013e31822bbcc1","article-title":"Increased risk of colorectal cancer and dysplasia in patients with Crohn\u2019s colitis and primary sclerosing cholangitis","volume":"54","author":"Lindstr\u00f6m","year":"2011","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.bpg.2011.10.002_bib53","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2011.10.002_bib54","article-title":"Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients","author":"J\u00f8rgensen","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2011.10.002_bib55","first-page":"1","article-title":"Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease","author":"Brackmann","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.002_bib56","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","article-title":"Genome-wide association analysis in primary sclerosing cholangitis","volume":"138","author":"Karlsen","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.002_bib57","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/ibd.20886","article-title":"More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis","volume":"15","author":"Claessen","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.bpg.2011.10.002_bib58","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cgh.2010.09.020","article-title":"Colon neoplasms develop early in the course of inflammatory bowel disease and primary sclerosing cholangitis","volume":"9","author":"Thackeray","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2011.10.002_bib59","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1053\/jhep.2002.30695","article-title":"Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis","volume":"35","author":"Dvorchik","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.002_bib60","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/01.TP.0000058744.34965.38","article-title":"Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis","volume":"75","author":"Vera","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.bpg.2011.10.002_bib61","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/hep.510270308","article-title":"Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation","volume":"27","author":"Loftus","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.002_bib62","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrc1279","article-title":"The history of cancer epigenetics","volume":"4","author":"Feinberg","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bpg.2011.10.002_bib63","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1045","article-title":"The power and the promise of DNA methylation markers","volume":"3","author":"Laird","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bpg.2011.10.002_bib64","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/jsre.1999.5615","article-title":"Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma","volume":"84","author":"Ahrendt","year":"1999","journal-title":"J Surg Res"},{"key":"10.1016\/j.bpg.2011.10.002_bib65","first-page":"227","article-title":"Epigenetic alterations associated with cholangiocarcinoma (review)","volume":"22","author":"Isomoto","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bpg.2011.10.002_bib66","doi-asserted-by":"crossref","first-page":"923","DOI":"10.5858\/2007-131-923-MPOMCI","article-title":"Methylation profiles of multiple CpG island loci in extrahepatic cholangiocarcinoma versus those of intrahepatic cholangiocarcinomas","volume":"131","author":"Kim","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.bpg.2011.10.002_bib67","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ijc.20944","article-title":"Allele loss and epigenetic inactivation of 3p21.3 in malignant liver tumors","volume":"115","author":"Tischoff","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpg.2011.10.002_bib68","first-page":"1773","article-title":"Promoter methylation of INK4a\/ARF as detected in bile-significance for the differential diagnosis in biliary disease","volume":"9","author":"Klump","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bpg.2011.10.002_bib69","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10555-010-9207-6","article-title":"DNA methylation markers in colorectal cancer","volume":"29","author":"Kim","year":"2010","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.bpg.2011.10.002_bib70","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1476-4598-7-94","article-title":"Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers","volume":"7","author":"Ahlquist","year":"2008","journal-title":"Mol Cancer"},{"key":"10.1016\/j.bpg.2011.10.002_bib71","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1155\/2007\/891967","article-title":"DNA methylation in colorectal cancer\u2013impact on screening and therapy monitoring modalities?","volume":"23","author":"Zitt","year":"2007","journal-title":"Dis Markers"},{"key":"10.1016\/j.bpg.2011.10.002_bib72","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bpg.2011.10.002_bib73","first-page":"3942","article-title":"Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis","volume":"58","author":"Hsieh","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2011.10.002_bib74","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1399-0004.2010.01546.x","article-title":"Identification of disease-associated DNA methylation in intestinal tissues from patients with inflammatory bowel disease","volume":"80","author":"Lin","year":"2011","journal-title":"Clin Genet"},{"key":"10.1016\/j.bpg.2011.10.002_bib75","first-page":"3225","article-title":"A gene hypermethylation profile of human cancer","volume":"61","author":"Esteller","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpg.2011.10.002_bib76","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/j.gastro.2007.03.003","article-title":"DNA hypermethylation of MAL: a promising diagnostic biomarker for colorectal tumors","volume":"132","author":"Lind","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.002_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/onc.2011.109","article-title":"SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis","author":"Lind","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.bpg.2011.10.002_bib78","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1158\/1055-9965.EPI-07-0518","article-title":"Highly methylated genes in colorectal neoplasia: implications for screening","volume":"16","author":"Zou","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.bpg.2011.10.002_bib79","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1373\/clinchem.2008.115808","article-title":"Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer","volume":"55","author":"deVos","year":"2009","journal-title":"Clin Chem"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691811000904?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691811000904?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T04:55:23Z","timestamp":1639803323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691811000904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":79,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1521691811000904"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2011.10.002","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}